It competitively inhibits the enzyme dihydropteroate synthase, which is essential for the production of folate in bacteria.
This disrupts bacterial metabolism and DNA/RNA synthesis, leading to the inhibition of bacterial growth and replication.
The selective toxicity of sulfaclozine towards bacteria is due to the fact that mammals obtain folate from dietary sources, rather than synthesizing it themselves.